Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tagatose Dose Ranging in Type 2 Diabetes
NCT00961662Phase 2Completed
- Sponsor
- Robert Lodder
- Start
- Feb 2008
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, randomised, single-blind trial of d-tagatose in type 2 diabetes mellitus (T2DM), sponsored by Robert Lodder. Primary endpoint: Change From Baseline HbA1c at 6 months. Started Feb 2008; status: completed.
02
Drugs
d-tagatose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00961662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961662.